Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | conserved protein, unknown function | 0.0479 | 1 | 0.5 |
Loa Loa (eye worm) | cuticular endochitinase | 0.0302 | 0.2004 | 0.2004 |
Plasmodium vivax | hypothetical protein, conserved | 0.0479 | 1 | 0.5 |
Brugia malayi | Endochitinase | 0.0338 | 0.3645 | 0.2052 |
Toxoplasma gondii | hypothetical protein | 0.0479 | 1 | 0.5 |
Loa Loa (eye worm) | chitinase I | 0.0302 | 0.2004 | 0.2004 |
Entamoeba histolytica | chitinase, putative | 0.0302 | 0.2004 | 0.5 |
Onchocerca volvulus | 0.0479 | 1 | 1 | |
Mycobacterium ulcerans | chitinase/cellulase | 0.0257 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0479 | 1 | 1 |
Mycobacterium ulcerans | chitinase/cellulase | 0.0257 | 0 | 0.5 |
Onchocerca volvulus | Putative endochitinase | 0.0338 | 0.3645 | 0.2052 |
Loa Loa (eye worm) | hypothetical protein | 0.0479 | 1 | 1 |
Brugia malayi | endochitinase | 0.0338 | 0.3645 | 0.2052 |
Onchocerca volvulus | 0.0479 | 1 | 1 | |
Leishmania major | chitinase | 0.0302 | 0.2004 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0479 | 1 | 0.5 |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0479 | 1 | 0.5 |
Onchocerca volvulus | Putative endochitinase | 0.0338 | 0.3645 | 0.2052 |
Onchocerca volvulus | Putative endochitinase | 0.0338 | 0.3645 | 0.2052 |
Loa Loa (eye worm) | microfilarial chitinase | 0.0294 | 0.1641 | 0.1641 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0479 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible chitinase | 0.0257 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 8 mm | Antifungal activity against Candida albicans at 250 ug/ml after 72 hrs by disc diffusion method | ChEMBL. | No reference |
IZ (functional) | = 8 mm | Antibacterial activity against Escherichia coli at 250 ug/ml after 24 to 45 hrs by disc diffusion method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.